Your browser doesn't support javascript.
loading
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous.
Difilippo, Valeria; Saba, Karim H; Styring, Emelie; Magnusson, Linda; Nilsson, Jenny; Nathrath, Michaela; Baumhoer, Daniel; Nord, Karolin H.
Afiliação
  • Difilippo V; Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden.
  • Saba KH; Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden.
  • Styring E; Department of Orthopedics, Lund University, Skåne University Hospital, Lund, Sweden.
  • Magnusson L; Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden.
  • Nilsson J; Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden.
  • Nathrath M; Children's Cancer Research Centre and Department of Pediatrics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Department of Pediatric Oncology, Klinikum Kassel, Kassel, Germany.
  • Baumhoer D; Bone Tumour Reference Centre at the Institute of Pathology, University Hospital and University of Basel, Basel, Switzerland.
  • Nord KH; Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden. Electronic address: karolin.hansen_nord@med.lu.se.
Lab Invest ; 104(1): 100283, 2024 01.
Article em En | MEDLINE | ID: mdl-37931683
ABSTRACT
Osteosarcoma is the most common primary bone malignancy, often detected in children and adolescents and commonly associated with TP53 alterations along with a high number of chromosomal rearrangements. However, osteosarcoma can affect patients of any age, and some tumors display less genetic complexity. Besides TP53 variants, data on key driving mutations are lacking for many osteosarcomas, particularly those affecting adults. To detect osteosarcoma-specific alterations, we screened transcriptomic and genomic sequencing and copy number data from 150 bone tumors originally diagnosed as osteosarcomas. To increase the precision in gene fusion detection, we developed a bioinformatic tool denoted as NAFuse, which extracts gene fusions that are verified at both the genomic and transcriptomic levels. Apart from the already reported genetic subgroups of osteosarcoma with TP53 structural variants, or MDM2 and/or CDK4 amplification, we did not identify any recurrent genetic driver that signifies the remaining cases. Among the plethora of mutations identified, we found genetic alterations characteristic of, or similar to, those of other bone and soft tissue tumors in 8 cases. These mutations were found in tumors with relatively few other genetic alterations or in adults. Due to the lack of clinical context and available tissue, we can question the diagnosis only on a genetic basis. However, our findings support the notion that osteosarcomas with few chromosomal alterations or adult onset seem genetically distinct from conventional osteosarcomas of children and adolescents.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article